Atamyo Therapeutics Presents Promising Results in the First Patients Treated With Its ATA-200 Gene Therapy in the Clinical Trial Targeting LGMD-R5 Limb-Girdle Muscular Dystrophy
· us & europe contacts: [email protected]
AI Briefing
- ATA-200 shows promise in treating LGMD-R5 Limb-Girdle Muscular Dystrophy
- First patients treated in clinical trial with ATA-200 gene therapy
- Promising results reported in early-stage trial
Advertisement